On Wednesday 8th June 2022, our annual ‘Meet the Portfolio’ showcase returned to the Royal Society of Chemistry after a 2-year COVID-19-related hiatus.
The event brought together 23 of our innovative EIS portfolio companies from the university spin-out sector and it was a great way for them to showcase their ground-breaking technologies. The evening was a success with over 200 investors, financial advisors, clients and colleagues in attendance.
Many thanks to all the companies that exhibited:
If you would like to register your interest to attend our 2023 event please email email@example.com.
To find out more about the Parkwalk portfolio or investing in university spin-outs, please contact out sales team. Our Opportunities EIS fund is open all year round, offering a diverse portfolio of five companies per subscription. The fund invests in EIS qualifying companies, spun-out from UK universities, across a range of investment stages from Series A-C and across different sectors from Digital Health to Life Sciences, Agri-tech to Hardware and much more. For more information see our website page here, or contact our sales team email at sales@parkwalkadvisors or call 0207 759 2285.
Parkwalk Advisors Limited (Parkwalk) is authorised and regulated by the Financial Conduct Authority: FRN 502237. Investments referred to in this news article are not suitable for all investors. Capital is at risk and investors may not get back the full amount invested. Tax reliefs subject to individual circumstances. Any investment in a Parkwalk product must only be made on the basis of the terms of the full Information Memorandum. Tax treatment depends on the individual circumstances of each investor. Parkwalk is not able to provide advice as to the suitability of investing in any product.